Expanded access, also known as compassionate use, is a process by which a patient can petition both the maker of an experimental treatment and the US Food and Drug Administration for access to the treatment outside a clinical trial. The Regan-Udall Foundation has created an Expanded Access Navigator to educate patients and their physicians about the process and to help locate necessary information for application. The Navigator is separated into sections specifically for patients and physicians, so that information can be found more quickly. For more information about the Expanded Access Navigator, click here: http://bit.ly/2tGlNjV
- What information can the donation of one patient’s tumor yield about metastasis?
- What is the iMPACT Program and how will it bring diversity to clinical trials?
- How is it possible that a great many promising cancer drugs create a problem for research and trials?
- Research Ethics Education a critical priority for WCGF: New Grant Opportunities Offered.
- How are physicians and researchers working to make clinical trials more diverse?